Tilray Inc (NASDAQ:TLRY - Get Free Report) traded down 2.9% during mid-day trading on Friday . The company traded as low as $1.50 and last traded at $1.51. 8,288,460 shares were traded during mid-day trading, a decline of 67% from the average session volume of 25,282,244 shares. The stock had previously closed at $1.55.
Analyst Upgrades and Downgrades
Separately, Roth Mkm dropped their price objective on shares of Tilray from $2.00 to $1.75 and set a "neutral" rating on the stock in a report on Friday, October 11th.
Check Out Our Latest Stock Report on TLRY
Tilray Price Performance
The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.57 and a current ratio of 2.47. The firm has a market cap of $1.35 billion, a PE ratio of -5.57 and a beta of 2.14. The stock has a 50 day simple moving average of $1.68 and a two-hundred day simple moving average of $1.79.
Tilray (NASDAQ:TLRY - Get Free Report) last issued its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, hitting analysts' consensus estimates of ($0.04). Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The business had revenue of $200.00 million for the quarter, compared to analysts' expectations of $218.70 million. During the same quarter last year, the company earned ($0.10) EPS. The business's revenue was up 13.0% on a year-over-year basis. Sell-side analysts expect that Tilray Inc will post -0.14 earnings per share for the current year.
Hedge Funds Weigh In On Tilray
Several hedge funds and other institutional investors have recently added to or reduced their stakes in TLRY. Prospect Financial Services LLC acquired a new stake in Tilray in the 2nd quarter worth about $26,000. Ferguson Wellman Capital Management Inc. purchased a new position in Tilray in the 3rd quarter valued at $26,000. Signature Estate & Investment Advisors LLC purchased a new stake in shares of Tilray during the second quarter worth $29,000. Jeppson Wealth Management LLC acquired a new stake in Tilray in the 2nd quarter valued at about $33,000. Finally, Vanguard Capital Wealth Advisors purchased a new position in Tilray during the second quarter worth approximately $34,000. 9.35% of the stock is owned by hedge funds and other institutional investors.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
